🏛️ Verified NIH Record • Updated 2026-04-09
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias (NCT06765356)
🔵 Active, Not Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: Vivek Reddy
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the FARAPULSE catheter system (FARAWAVE catheter used in combination with the FARASTAR generator), to treat patients with atrial fibrillation during clinically-indicated ablation procedures
Who can join: Review the eligibility criteria below.
Location: Arrhythmia Research Group — Jonesboro, Arkansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- Arrhythmia Research Group — Jonesboro, Arkansas
- Cardiology Associates Medical Group — Ventura, California
- Naples Comprehensive Health — Naples, Florida
- Mount Sinai Morningside — New York, New York
- The Mount Sinai Hospital — New York, New York
- Ohio Health Research Institute — Columbus, Ohio
- UPMC Pinnacle Hospitals — Harrisburg, Pennsylvania
- Trident Medical Center — North Charleston, South Carolina
- Sentara Health Research Center — Virginia Beach, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Persistent Atrial Fibrillation
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
- SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
- Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
- STOP Persistent AF PAS — Hartford, Connecticut
- REPRESENT-PF Registry — New York, New York
Explore by condition: All Persistent Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.